Sara Gaafar Ibnauf Suliman: The Changing Role of Bariatric Surgery in the GLP-1 Era
Sara Gaafar Ibnauf Suliman, President of Obesity Medicine Section at IFSO International Federation for the Surgery and other therapies for Obesity (IFSO), shared a post on LinkedIn:
“GLP1 receptor agonist usage has expanded exponentially, making some question the role of metabolic bariatric surgery (MBS) in the management of obesity.
In this article published today in the The Lancet Obstetrics, Gynaecology, and Women’s Health we present a balanced view on why both MBS and GLP1RAs have an important role to play in the management of obesity and particularly in women.”
Title: Obesity medications in women’s health: is metabolic bariatric surgery still relevant?
Authors: Sara G I Suliman, Ali Aminian, Mohammed Al-Hadad, Alexander Dimitri Miras, Dimitris Papamargaritis, Melanie J Davies, Susan E Ozanne, Claire L Meek, Tricia M-M Tan
Stay updated with Hemostasis Today.
-
Oct 1, 2026, 23:16Ahmed Reda: New Ferritin Cutoffs For Iron Deficiency – Ash 2026
-
Oct 1, 2026, 23:04Mario Ottiglio: Launching New Initiative During UNGA81 Week through WCSCD
-
Oct 1, 2026, 22:56Suvro Sankha Datta: Can Blood Group Genotyping Help in Distinguishing between the Aweak and Ah with Similar Serological Results
-
Oct 1, 2026, 22:50Ifeanyichukwu Ifechidere: D-dimer – Why is This Test Being Ordered – and What is It Actually Telling You?
-
Oct 1, 2026, 15:44A Century of Von Willebrand Disease Awareness – EHC
-
Oct 1, 2026, 15:31Andreas Calatzis: The Power of Teamwork in Postpartum Hemorrhage
-
Oct 1, 2026, 15:09Halimat Olaniyan: The Role of Transfusion Medicine in Sickle Cell Disease Care
-
Oct 1, 2026, 14:58Samir Kumar Beura: Modern Approaches to Platelet Structure and Function
-
Oct 1, 2026, 14:39Understanding the FDA Pathway for Hematology Product Development – American Society of Hematology